Researchers launch major study to unravel mysteries of muscle disease
NCT ID NCT00017914
First seen Jun 26, 2026 · Last updated Aug 05, 2026 · Updated 5 times
Summary
This study aims to learn more about myositis, a group of diseases that cause muscle inflammation and damage. Researchers will observe up to 1,200 children and adults with myositis, along with healthy volunteers, to track changes in the immune system and other health problems over time. Participants undergo various tests like blood work, muscle strength assessments, and imaging, but no new treatments are being tested.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATOMYOSITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory University
COMPLETEDAtlanta, Georgia, 30322, United States
-
NIEHS Clinical Research Unit (CRU)
RECRUITINGResearch Triangle Park, North Carolina, 27709, United States
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
-
Texas Scottish Rite Hospital
COMPLETEDDallas, Texas, 75219, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood test unlock the secrets of brain autoimmune diseases?
- Can a targeted immune drug calm rare muscle inflammation?
- Engineered immune cells take aim at Hard-to-Treat muscle disease
- Could a simple injection dissolve painful calcium lumps in rare diseases?
- Engineered immune cells take aim at childhood autoimmune diseases
- Wearable sensors could revolutionize monitoring of rare muscle disease